Loading live market data…

CureVac N.V.

NASDAQ:CVAC

$4.66 USD

$0 (0.0%)

Volume
728.78K
Average Volume
1.17M
Market Capitalization
$1.05B
P/E Ratio
5.64
Dividend Yield
0.00%
Price Target
$21.00
Year High
$5.72
Year Low
$2.48
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.70
Source Headline
CureVac sues Moderna for patent infringement over COVID-19 vaccines

German biotech company CureVac sued Moderna in Delaware federal court on Friday, alleging ​that Moderna's COVID-19 vaccine Spikevax infringed CureVac ‌patents related to messenger RNA (mRNA) technology.

reuters.com - 2026-04-24 16:52:11

Get CVAC Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

CVAC Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$21.00

3 analysts

CVAC Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-06-26 UBS Downgrade Buy Neutral
2025-06-13 Jefferies Downgrade Buy Hold
2025-05-28 JMP Securities Maintain Market Outperform Market Outperform
2025-04-30 UBS Maintain Buy Buy
2025-02-14 JMP Securities Maintain Market Outperform Market Outperform
2024-09-16 JMP Securities Maintain Market Outperform Market Outperform
2024-08-16 JMP Securities Maintain Market Outperform Market Outperform
2024-07-03 JMP Securities Maintain Market Outperform Market Outperform
2024-04-25 Leerink Partners Downgrade Outperform Market Perform
2021-12-31 Deutsche Bank Maintain Hold Hold
2021-10-22 Deutsche Bank Maintain Hold Hold
2021-06-17 B of A Securities Downgrade Buy Neutral
2021-06-16 B of A Securities Downgrade Buy Neutral
2021-04-26 Guggenheim Maintain Buy Buy
2020-12-10 Credit Suisse Downgrade Neutral Underperform
2020-09-08 Credit Suisse Maintain Neutral Neutral
2020-09-08 Jefferies Maintain Hold Hold
2020-09-08 B of A Securities Maintain Buy Buy